UChicago Medicine secures approval to design $633M cancer center

University of Chicago Medicine received approval from the Illinois Health Facilities and Services Review Board to begin designing and planning the state’s first freestanding cancer center, which will cost $633 million.

Advertisement

If the project receives regulatory approval, construction will begin in 2023 and the center will open in 2026, according to a March 15 UChicago news release.

The project will span 500,000 square feet on the city’s South Side. It will add 128 beds, which will be dedicated to patients with cancer, to the hospital’s campus, freeing other beds for patients with complex and acute care needs.

The cancer center will also address healthcare inequities for residents of the city’s South Side, who have a higher cancer burden and less access to care, UChicago said.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Capital

Advertisement

Comments are closed.